Results 1-13 of 13 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2016 | Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression. | Liu, J; Yang, HI ; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Chen, CJ | HEPATOLOGY 64(2), 381-389 | |||
2 | 2016 | Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis | Chien, J; Liu, J; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Journal of gastroenterology and hepatology 31(12), 1971-1977 | |||
3 | 2016 | Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study. | Lin, YJ; Shaw, TG; Yang, HI ; Lu, SN; Jen, CL; Wang, LY; Wong, KH; Chan, SY; Yuan, Y; L'Italien, G; Chen, CJ ; Lee, MH | Liver international 37(2), 179-186 | |||
4 | 2016 | Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. | Hoang, JK; Yang, HI ; Le, A; Nguyen, NH; Lin, D; Vu, VD; Chaung, K; Nguyen, V; Trinh, HN; Li, J; Zhang, JQ; Chen, CJ ; Nguyen, MH | Medicine 95(31), e4433 | |||
5 | 2016 | Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. | Yang, HI ; Nguyen, N; Hoang, J; Kim, Y; Vu, V; Le, A; Chaung, K; Nguyen, V; Trinh, H; Li, J; Zhang, J; Hsing, A; Chen, CJ ; Nguyen, MH | Alimentary pharmacology & therapeutics 44(8), 846-855 | |||
6 | 2016 | The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. | Hu, HH; Liu, J; Lin, YL; Luo, WS; Chu, YJ; Chang, CL; Jen, CL; Lee, MH; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Gut 65, 1514-1521 | |||
7 | 2016 | Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer’s Disease | Chen, YC; Hsiao, CJ; Jung, CC; Hu, HH; Chen, JH; Lee, WC; Chiou, JM; Chen, TF; Sun, Y; Wen, LL; Yip, PK; Chu, YM; Chen, CJ ; Yang, HI | Scientific reports 6, 36155 | |||
8 | 2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang, HI ; Tseng, TC; Liu, J; Lee, MH; Liu, CJ; Su, TH; Batrla-Utermann, R; Chan, HL; Kao, JH; Chen, CJ | Clinical gastroenterology and hepatology 14(3), 461-468.e2 | |||
9 | 2016 | Mediation effect of hepatitis B and C on mortality. | Huang, YT ; Freeman, JR; Yang, HI ; Liu, J; Lee, MH; Chen, CJ | European journal of epidemiology 31(6), 625-33 | |||
10 | 2016 | Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk. | Huang, YT ; Yang, HI ; Liu, J; Lee, MH; Freeman, JR; Chen, CJ | EPIDEMIOLOGY 27(1), 14-20 | |||
11 | 2016 | Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma. | Liu, J; Yang, HI ; Lee, MH; Jen, CL; Hu, HH; Lu, SN; Wang, LY; You, SL; Huang, YT ; Chen, CJ | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 25(4), 693-9 | |||
12 | 2016 | Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B | Poh, Z; Shen, L; Yang, HI ; Seto, WK; Wong, VW; Lin, CY; Goh, BG; Chang, PJ; Chan, HL; Yuen, MF; Chen, CJ ; Tan, CK | GUT 65(5), 887-894 | |||
13 | 2016 | Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. | Wu, HC; Shen, J; Yang, HI ; Tsai, WY; Chen, CJ ; Santella, RM | World journal of hepatology 8(5), 301-306 |